Caliway Biopharmaceuticals (6919.TW) Q2 2025 Earnings

5MayConfirmed
Q4 2024
Q1 2025
Q2 2025
-1.36
-0.94
-0.52
-0.1

Details

Expected EPS
-0.12883564512
Actual EPS
-0.09991335744
Surprise EPS
0.03
Surprise Percent
+22.45%

Description

Caliway Biopharmaceuticals (6919.TW) has reported earnings of -0.09991335744 per share for Q2 2025.

0 Comments

Share your thoughts